These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 24919928

  • 1. The association of -330 interleukin-2 gene polymorphism and HLA-DR15 allele in Iranian patients with multiple sclerosis.
    Sayad A.
    Int J Immunogenet; 2014 Aug; 41(4):330-4. PubMed ID: 24919928
    [Abstract] [Full Text] [Related]

  • 2. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R, Samadzadeh S, Sabokbar T, Siroos B, Armaki SA, Aslanbeiki B, Ghelman M, Taheri T, Shakoori A.
    J Neurol Sci; 2014 Oct 15; 345(1-2):92-6. PubMed ID: 25064442
    [Abstract] [Full Text] [Related]

  • 3. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.
    Shahbazi M, Roshandel D, Omidnyia E, Rshaidbaghan A.
    Clin Immunol; 2011 Jun 15; 139(3):277-81. PubMed ID: 21396892
    [Abstract] [Full Text] [Related]

  • 4. High frequency of the IL-2 -330 T/HLA-DRB1*1501 haplotype in patients with multiple sclerosis.
    Shahbazi M, Roshandel D, Ebadi H, Fathi D, Zamani M, Boghaee M, Mohammadhoseeeni M, Rshaidbaghan A, Bakhshandeh A, Shahbazi S.
    Clin Immunol; 2010 Oct 15; 137(1):134-8. PubMed ID: 20594918
    [Abstract] [Full Text] [Related]

  • 5. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
    Nejati P, Attar M, Rahimian M, Fathi D, Shahbazi M.
    Iran J Immunol; 2017 Sep 15; 14(3):231-239. PubMed ID: 28919586
    [Abstract] [Full Text] [Related]

  • 6. Are IL2 promoter polymorphisms associated with MS in Iranian patients? - We do not know.
    Jabalameli MR, Zahednasab H.
    Int J Immunogenet; 2014 Dec 15; 41(6):528-9. PubMed ID: 25399512
    [No Abstract] [Full Text] [Related]

  • 7. Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II.
    Ouadghiri S, El Alaoui Toussi K, Brick C, Ait Benhaddou EH, Benseffaj N, Benomar A, El Yahyaoui M, Essakalli M.
    Pathol Biol (Paris); 2013 Dec 15; 61(6):259-63. PubMed ID: 23849771
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis.
    Rafiei M, Zarif Yeganeh M, Sheikholeslami S, Gozalpour E, Ghaffarpour M, Hedayati M.
    J Neurol Sci; 2012 Sep 15; 320(1-2):22-5. PubMed ID: 22698480
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM, Pereira C, Bettencourt A, Carvalho C, Couto AR, Leite MI, Marta M, Freijo M, Costa PP, Mendonça D, Monteiro L, Armas JB, Martins B.
    J Neurol Sci; 2007 Jul 15; 258(1-2):69-74. PubMed ID: 17412364
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R, Uxa L, Bratina A, Bosco A, Srinivasaraghavan B, Minagar A, Ukmar M, Benedetto Sy, Zorzon M.
    Int Rev Neurobiol; 2007 Jul 15; 79():521-35. PubMed ID: 17531857
    [Abstract] [Full Text] [Related]

  • 14. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
    Wu JS, James I, Wei Qiu, Castley A, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG.
    Mult Scler; 2010 May 15; 16(5):526-32. PubMed ID: 20207784
    [Abstract] [Full Text] [Related]

  • 15. The association of -475 and -631 interleukin-2 gene polymorphism with multiple sclerosis in Iranian patients.
    Sayad A, Allameh A, Sayad A, Noruzinia M, Akbari MT, Sarzaeem A, Akbar A, Haji Hoseini R.
    Cell J; 2013 May 15; 15(2):124-9. PubMed ID: 23862113
    [Abstract] [Full Text] [Related]

  • 16. [Association of HLA-DRB1 and -DPB1 allele polymorphism with multiple sclerosis in Chinese Han population from Southern areas].
    Wu XM, Zhang KN, Wang CD, Xiong YQ, Liu Z, Qu XH, Xie XF.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 23; 87(39):2741-4. PubMed ID: 18167262
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of the multiple sclerosis associated -330 promoter polymorphism in IL2 allelic expression.
    Matesanz F, Fedetz M, Leyva L, Delgado C, Fernández O, Alcina A.
    J Neuroimmunol; 2004 Mar 23; 148(1-2):212-7. PubMed ID: 14975604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.